Sign in to continue:

Wednesday, February 25th, 2026

Standard Chartered PLC FY 2025 Pillar 3 Disclosures and Board of Directors Announcement 1

Standard Chartered PLC Releases FY 2025 Pillar 3 Disclosures

Date of Announcement: 24 February 2026

Standard Chartered PLC has officially released its FY 2025 Pillar 3 Disclosures, a crucial regulatory report for investors and stakeholders. The disclosures have been submitted to the Financial Conduct Authority (FCA) and will be accessible via the FCA’s National Storage Mechanism, as well as on the Company’s official website.

Key Points for Investors

  • Pillar 3 Disclosure Release: The release of the FY 2025 Pillar 3 Disclosures provides transparency into Standard Chartered’s risk profile, capital adequacy, and regulatory compliance. This is a regulatory requirement and is closely watched by investors, analysts, and regulators.
  • Availability: The disclosures will be available for inspection at the FCA’s National Storage Mechanism (link) and on the Standard Chartered website (link).
  • Investor and Media Contacts: Manus Costello is the point of contact for investor queries ([email protected], +44 (0) 20 7885 0017), and Shaun Gamble for media queries ([email protected], +44 20 7885 5934).

Board of Directors – Updated Composition

The announcement also details the current composition of Standard Chartered PLC’s Board of Directors. This is important for shareholders, as leadership changes can impact strategic direction and investor confidence:

  • Chair: Maria da Conceicao das Neves Calha Ramos
  • Executive Director: William Thomas Winters, CBE (Group Chief Executive)
  • Independent Non-Executive Directors: Shirish Moreshwar Apte, Jacqueline Hunt, Diane Enberg Jurgens, Robin Ann Lawther, CBE, Lincoln Leong Kwok Kuen, Philip George Rivett (Senior Independent Director), David Tang, Linda Yi-chuang Yueh, CBE

What Shareholders Need to Know – Potentially Price Sensitive Information

  • Regulatory Transparency: The release of Pillar 3 Disclosures is significant as it provides stakeholders with comprehensive information about the bank’s capital position, risk exposures, and regulatory compliance. These factors are directly related to the bank’s financial stability and can influence share price.
  • Leadership Stability: Confirmation of the Board’s composition, including the reappointment or continuation of key directors, may assure investors of leadership stability and strategic continuity. Any changes in board members can be a signal to the market and may impact investor sentiment.
  • No Immediate Financial Results: The announcement does not contain detailed financial results or guidance, but directs investors to where they can access the full disclosures. The actual contents of the Pillar 3 report (once reviewed by investors) could potentially affect the share price depending on the risk and capital position revealed.

Investor Actions

Investors are encouraged to review the full FY 2025 Pillar 3 Disclosures upon release, as these documents may contain information that could influence valuation, risk appetite, and investment decisions. The disclosures should be analyzed for any material changes in risk profile, capital adequacy, or compliance that could impact Standard Chartered’s share price.

Conclusion

While the current announcement serves primarily as a notification of the release of regulatory disclosures and an update on board composition, these are important signals for investors. The actual Pillar 3 Disclosures, once available, may contain material information impacting share value, particularly regarding capital adequacy and risk management.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review the full regulatory disclosures and consult professional advisors before making any investment decisions. The information provided reflects the contents of the official announcement and is not a substitute for the actual Pillar 3 Disclosures.

View STANCHART Historical chart here



CARsgen Therapeutics Holdings Limited Announces Board Meeting to Approve 2025 Annual Results on March 6, 2026 1

CARsgen Therapeutics Holdings Limited Announces Upcoming Board Meeting to Approve 2025 Annual Results Key Highlights: CARsgen Therapeutics Holdings Limited (CARsgen, Stock Code: 2171) has officially announced that its Board of Directors will convene on...

JD Logistics Board Meeting and 2025 Annual Results Announcement with Conference Call Details

JD Logistics Announces Board Meeting and Earnings Call for 2025 Annual Results JD Logistics Schedules Board Meeting and Earnings Call for 2025 Annual Results JD Logistics, Inc. (HKEX: 2618) has released an important announcement...

China High Precision Automation Group Limited Supplemental Announcement on 2025 Share Option Scheme and Performance Targets 12

China High Precision Automation Group Supplemental Announcement Analysis China High Precision Automation Group Limited Issues Supplemental Announcement on Share Option Scheme Key Points for Investors Large Share Option Grant: On 13 February 2025, China...

   Ad